Clinical Trial Update: Study of TOP1630 for Dry Eye Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for TOP1630 in Dry Eye Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• TOP1630

Snippet

Sponsor: Topivert Pharma Ltd | Conditions: Dry Eye Syndrome | Phase 2, Phase 3 | Status: COMPLETED